D’Ieteren NV (0ON7)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 175.65 |
|---|---|
| 52-week range | 142.25 – 198.26 |
| Return, 1 month / 3 months | +7.6% / +1.4% |
| Return, 1 year / 3 years | +10.6% / +75.6% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 29.0% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 1.21M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
D'Ieteren is a Belgian company based in Brussels that distributes Volkswagen Group cars in its home market, representing brands such as Volkswagen, Audi, Skoda, Seat and Porsche through dealership and service networks. It also controls Belron, a vehicle glass repair and replacement business that serves motorists and insurers under local brand names in many countries. Alongside these activities the group holds other mobility and after-sales operations, giving it a mix of vehicle distribution, glass repair and related services for private and business customers.
On this site D’Ieteren NV appears as a stock on the London Exchange (UK), code 0ON7, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
D’Ieteren NV (0ON7) trades on the London Exchange in UK. It last closed at EUR 175.65 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,740 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.6% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.2% | ||
| From 52-week high | -10.5% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 2.8% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +7.6% |
| 3 months | +1.4% |
| 6 months | −0.0% |
| 1 year | +10.6% |
| 3 years | +75.6% |
| 5 years | +72.2% |
Signals
| 50-day / 200-day average | 170.86 / 173.65 |
|---|---|
| Golden / death cross (60 days) | Death, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2026 | EUR 1.4000 |
| 10 Jun 2025 | EUR 1.1200 |
| 10 Dec 2024 | EUR 51.8000 |
| 11 Jun 2024 | EUR 2.6250 |
| 6 Jun 2023 | EUR 2.1000 |
| 7 Jun 2022 | EUR 1.4700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.